Not checked for notices yet.

High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes

Fanny Onodi, Chahrazed Maherzi-Mechalikh, Chahrazed Maherzi-Mechalikh and 21 more

Frontiers in Oncology · 2018

doi:10.3389/fonc.2018.00517

Cited by papers we hold 3

Development of Peptide-Based Vaccines for Cancer · 2022
No notice
Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines · 2021
No notice
Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study? · 2019
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.